January 8, 2026 · Form 4 insider transaction
Friend John E. II sold 150,000 shares of Kazia Therapeutics Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 181 days after the transaction.
Represents a board-approved award of 150,000 restricted share units ("RSUs"), approved by the Remuneration Committee on January 8, 2026. One-third of the RSUs vest on January 8, 2027, and the remaining two-thirds vest in equal yearly tranches thereafter. Each RSU represents a contingent right to receive one ADS of the Issuer.